Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RD Néphrologie is a specialized clinical research organization (CRO) and biotechnology company focused on the field of nephrology and renal replacement therapies. Based in Montpellier, France, the company provides comprehensive services for the development and evaluation of medical devices, dialysis techniques, and pharmacological treatments for kidney diseases. Their expertise spans from physiological studies and pilot trials to large-scale multicenter clinical investigations. RD Néphrologie is recognized for its contributions to optimizing hemodiafiltration and improving patient outcomes in end-stage renal disease. The company also engages in independent research projects aimed at identifying new biomarkers and therapeutic strategies for chronic kidney disease. By bridging the gap between academic research and industrial application, they facilitate the translation of innovative renal care solutions to the clinical setting.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RD Néphrologie.